Matches in Nanopublications for { ?s ?p "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP212573.RAyQuIHShBhVoKhy9yd308j6XGjXfAqNju-BfPqm1T-k0130_assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212573.RAyQuIHShBhVoKhy9yd308j6XGjXfAqNju-BfPqm1T-k0130_provenance.
- assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP842936.RAlbEjaJduZAA2cFNJr6NNcZQ6ebDThAr_yKk7Kkqe7Zc130_assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842936.RAlbEjaJduZAA2cFNJr6NNcZQ6ebDThAr_yKk7Kkqe7Zc130_provenance.
- NP842937.RAmChHCx00QHZP2NMu9XF3z94Hmwy3guZYriOzAMPrrlQ130_assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842937.RAmChHCx00QHZP2NMu9XF3z94Hmwy3guZYriOzAMPrrlQ130_provenance.
- NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260402.RAxuMpVc-Cv-wZhq2g3PyGI85_VqwIkGtAErbA11P8GLA130_provenance.
- NP907085.RAJyYSmnGu4Y4F89WiaL_1h1obhd8koz0j4CA9diF5bXc130_assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907085.RAJyYSmnGu4Y4F89WiaL_1h1obhd8koz0j4CA9diF5bXc130_provenance.
- NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_assertion description "[By contrast, other prospective miR-15/miR-16 targets in the dataset (BCL-2 and cyclin D1) were not upregulated in CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842932.RAN9rADkev0AgM0VgP5k-ylu6LprWx7s6fdYUZYq0lIAk130_provenance.